SHEILA BROWNING: Open Payments
NPI 1558721886 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 21 payments from 10 companies in 2025. Trend: 2023 $428 · 2024 $225 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| Organogenesis Inc. | 1 | $125 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Optinose US, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Reprise Biomedical, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: PURAPLY WOUND MATRIX, FARXIGA, AIRSUPRA, PAXLOVID, MOUNJARO, REXULTI, Ozempic, Xhance.
Industry payments across TX — which companies pay providers there.
